{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:15:20Z","timestamp":1788869720780,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"DOI":"10.1038\/s10038-026-01514-6","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:40:23Z","timestamp":1788824423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Broadening the Okur-Chung syndrome phenotype: adult-onset metabolic features and a contiguous 20p13 deletion in a Turkish multicenter cohort"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5068-0380","authenticated-orcid":false,"given":"\u00c7a\u011fr\u0131","family":"Do\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2432-9279","authenticated-orcid":false,"given":"Alper","family":"Gezdirici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"\u00d6z\u0131\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samim","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u00e7a","family":"Aykut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asude","family":"Durmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Y\u0131lmaz","family":"G\u00fcle\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2635-443X","authenticated-orcid":false,"given":"Mukaddes Feyza","family":"Baltac\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyy\u00fcp","family":"\u00dc\u00e7tepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Ceylaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Tar\u0131k","family":"Alay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rem","family":"Kalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0669-8230","authenticated-orcid":false,"given":"K\u00fcbra","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Burak","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"1514_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00439-016-1661-y","volume":"135","author":"V Okur","year":"2016","unstructured":"Okur V, Cho MT, Henderson L, Retterer K, Schneider M, Sattler S, et al. De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features. Hum Genet. 2016;135:699\u2013705. https:\/\/doi.org\/10.1007\/s00439-016-1661-y.","journal-title":"Hum Genet"},{"key":"1514_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11010-011-0963-6","volume":"356","author":"I Ceglia","year":"2011","unstructured":"Ceglia I, Flajolet M, Rebholz H. Predominance of CK2alpha over CK2alpha\u2019 in the mammalian brain. Mol Cell Biochem. 2011;356:169\u201375. https:\/\/doi.org\/10.1007\/s11010-011-0963-6.","journal-title":"Mol Cell Biochem"},{"key":"1514_CR3","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1093\/emboj\/20.19.5320","volume":"20","author":"K Niefind","year":"2001","unstructured":"Niefind K, Guerra B, Ermakowa I, Issinger OG. Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. EMBO J. 2001;20:5320\u201331. https:\/\/doi.org\/10.1093\/emboj\/20.19.5320.","journal-title":"EMBO J"},{"key":"1514_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/jhg.2017.73","volume":"62","author":"J Trinh","year":"2017","unstructured":"Trinh J, H\u00fcning I, Budler N, Hingst V, Lohmann K, Gillessen-Kaesbach G. A novel de novo mutation in CSNK2A1: reinforcing the link to neurodevelopmental abnormalities and dysmorphic features. J Hum Genet. 2017;62:1005\u20136. https:\/\/doi.org\/10.1038\/jhg.2017.73.","journal-title":"J Hum Genet"},{"key":"1514_CR5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/cge.13196","volume":"93","author":"ATG Chiu","year":"2018","unstructured":"Chiu ATG, Pei SLC, Mak CCY, Leung GKC, Yu MHC, Lee SL, et al. Okur-Chung neurodevelopmental syndrome: eight additional cases with implications for phenotype and genotype expansion. Clin Genet. 2018;93:880\u201390. https:\/\/doi.org\/10.1111\/cge.13196.","journal-title":"Clin Genet"},{"key":"1514_CR6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/ajmg.a.38610","volume":"176","author":"CI Owen","year":"2018","unstructured":"Owen CI, Bowden R, Parker MJ, Patterson J, Patterson J, Price S, et al. Extending the phenotype associated with the CSNK2A1-related Okur-Chung syndrome\u2014a clinical study of 11 individuals. Am J Med Genet A. 2018;176:1108\u201314. https:\/\/doi.org\/10.1002\/ajmg.a.38610.","journal-title":"Am J Med Genet A"},{"key":"1514_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/hgv.2018.11","volume":"5","author":"M Akahira-Azuma","year":"2018","unstructured":"Akahira-Azuma M, Tsurusaki Y, Enomoto Y, Mitsui J, Kurosawa K. Refining the clinical phenotype of Okur-Chung neurodevelopmental syndrome. Hum Genome Var. 2018;5:18011. https:\/\/doi.org\/10.1038\/hgv.2018.11.","journal-title":"Hum Genome Var"},{"key":"1514_CR8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s10038-018-0434-y","volume":"63","author":"D Colavito","year":"2018","unstructured":"Colavito D, Del Giudice E, Ceccato C, Dalle Carbonare M, Leon A, Suppiej A. Are CSNK2A1 gene mutations associated with retinal dystrophy? Report of a patient carrier of a novel de novo splice site mutation. J Hum Genet. 2018;63:779\u201381. https:\/\/doi.org\/10.1038\/s10038-018-0434-y.","journal-title":"J Hum Genet"},{"key":"1514_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s10038-018-0559-z","volume":"64","author":"M Nakashima","year":"2019","unstructured":"Nakashima M, Tohyama J, Nakagawa E, Watanabe Y, Siew CG, Kwong CS, et al. Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures. J Hum Genet. 2019;64:313\u201322. https:\/\/doi.org\/10.1038\/s10038-018-0559-z.","journal-title":"J Hum Genet"},{"key":"1514_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000517977","volume":"13","author":"H Murakami","year":"2022","unstructured":"Murakami H, Uehara T, Enomoto Y, Nishimura N, Kumaki T, Kuroda Y, et al. Persistent hyperplastic primary vitreous with microphthalmia and coloboma in a patient with Okur-Chung neurodevelopmental syndrome. Mol Syndromol. 2022;13:75\u20139. https:\/\/doi.org\/10.1159\/000517977.","journal-title":"Mol Syndromol"},{"key":"1514_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-020-01096-w","volume":"21","author":"S Xu","year":"2020","unstructured":"Xu S, Lian Q, Wu J, Li L, Song J. Dual molecular diagnosis of tricho-rhino-phalangeal syndrome type I and Okur-Chung neurodevelopmental syndrome in one Chinese patient: a case report. BMC Med Genet. 2020;21:158. https:\/\/doi.org\/10.1186\/s12881-020-01096-w.","journal-title":"BMC Med Genet"},{"key":"1514_CR12","doi-asserted-by":"publisher","first-page":"300060521101706","DOI":"10.1177\/03000605211017063","volume":"49","author":"RH Wu","year":"2021","unstructured":"Wu RH, Tang WT, Qiu KY, Li XJ, Tang DX, Meng Z, et al. Identification of novel CSNK2A1 variants and the genotype\u2013phenotype relationship in patients with Okur-Chung neurodevelopmental syndrome: a case report and systematic literature review. J Int Med Res. 2021;49:3000605211017063. https:\/\/doi.org\/10.1177\/03000605211017063.","journal-title":"J Int Med Res"},{"key":"1514_CR13","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/s41380-024-02762-8","volume":"30","author":"JM Cruz-Gamero","year":"2025","unstructured":"Cruz-Gamero JM, Ballardin D, Lecis B, Zhang CL, Cobret L, Gast A, et al. Missense mutation in the activation segment of the kinase CK2 models Okur-Chung neurodevelopmental disorder and alters the hippocampal glutamatergic synapse. Mol Psychiatry. 2025;30:1497\u2013509. https:\/\/doi.org\/10.1038\/s41380-024-02762-8.","journal-title":"Mol Psychiatry"},{"key":"1514_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00439-021-02280-5","volume":"140","author":"I Dominguez","year":"2021","unstructured":"Dominguez I, Cruz-Gamero JM, Corasolla V, Dacher N, Rangasamy S, Urbani A, et al. Okur-Chung neurodevelopmental syndrome-linked CK2\u03b1 variants have reduced kinase activity. Hum Genet. 2021;140:1077\u201396. https:\/\/doi.org\/10.1007\/s00439-021-02280-5.","journal-title":"Hum Genet"},{"key":"1514_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.850661","volume":"9","author":"DM Caefer","year":"2022","unstructured":"Caefer DM, Phan NQ, Liddle JC, Balsbaugh JL, O\u2019Shea JP, Tzingounis AV, et al. The Okur-Chung neurodevelopmental syndrome mutation CK2K198R leads to a rewiring of kinase specificity. Front Mol Biosci. 2022;9:850661. https:\/\/doi.org\/10.3389\/fmolb.2022.850661.","journal-title":"Front Mol Biosci"},{"key":"1514_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/cge.14408","volume":"104","author":"N Belnap","year":"2023","unstructured":"Belnap N, Price-Smith A, Ramsey K, Leka K, Abraham A, Lieberman E, et al. Inherited CSNK2A1 variants in families with Okur-Chung neurodevelopmental syndrome. Clin Genet. 2023;104:607\u20139. https:\/\/doi.org\/10.1111\/cge.14408.","journal-title":"Clin Genet"},{"key":"1514_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.xhgg.2024.100379","volume":"6","author":"S Ramadesikan","year":"2025","unstructured":"Ramadesikan S, Showpnil IA, Marhabaie M, Daley A, Varga EA, Gurusamy U, et al. Expanding the phenotypic spectrum of CSNK2A1-associated Okur-Chung neurodevelopmental syndrome. Hum Genet Genomics Adv. 2025;6:100379. https:\/\/doi.org\/10.1016\/j.xhgg.2024.100379.","journal-title":"Hum Genet Genomics Adv"},{"key":"1514_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.2398","volume":"12","author":"H Nan","year":"2024","unstructured":"Nan H, Chu M, Zhang J, Jiang D, Wang Y, Wu L. Okur-Chung neurodevelopmental syndrome: implications for phenotype and genotype expansion. Mol Genet Genomic Med. 2024;12:e2398. https:\/\/doi.org\/10.1002\/mgg3.2398.","journal-title":"Mol Genet Genomic Med"},{"key":"1514_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2025.1589897","volume":"19","author":"ED Bagatelas","year":"2025","unstructured":"Bagatelas ED, Khan MM, Rushing GV. OCNDS core features are conserved across variants, with loop-region mutations driving greater symptom burden. Front Hum Neurosci. 2025;19:1589897. https:\/\/doi.org\/10.3389\/fnhum.2025.1589897.","journal-title":"Front Hum Neurosci"},{"key":"1514_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000530585","volume":"15","author":"D Zhuri","year":"2024","unstructured":"Zhuri D, Dusenkalkan F, Tunca Alparslan G, Gurkan H. A case of Okur-Chung neurodevelopmental syndrome with a novel, de novo variant on the CSNK2A1 gene in a Turkish patient. Mol Syndromol. 2024;15:43\u201350. https:\/\/doi.org\/10.1159\/000530585.","journal-title":"Mol Syndromol"},{"key":"1514_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00431-025-06347-7","volume":"184","author":"Yeter","year":"2025","unstructured":"Yeter, Kendir Demirkol B, Usluer Y, O\u011fuz E, Eser S, Yarar MH M, et al. Clinical and molecular results in 15 Turkish patients with Wiedemann-Steiner syndrome: identification of eight novel KMT2A variants and a case of dual molecular diagnosis in the CSNK2A1. Eur J Pediatr. 2025;184:512 https:\/\/doi.org\/10.1007\/s00431-025-06347-7.","journal-title":"Eur J Pediatr"},{"key":"1514_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/26330040241249763","volume":"5","author":"GV Rushing","year":"2024","unstructured":"Rushing GV, Sills J. Patient organization perspective: a research roadmap for Okur-Chung Neurodevelopmental Syndrome. Ther Adv Rare Dis. 2024;5:26330040241249763. https:\/\/doi.org\/10.1177\/26330040241249763.","journal-title":"Ther Adv Rare Dis"},{"key":"1514_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Das S, Gastier-Foster J, Grody WW, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"1514_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","volume":"22","author":"ER Riggs","year":"2020","unstructured":"Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020;22:245\u201357. https:\/\/doi.org\/10.1038\/s41436-019-0686-8.","journal-title":"Genet Med"},{"key":"1514_CR25","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71 https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1514_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ajmg.a.61405","volume":"182","author":"A Mart\u00ednez-Monseny","year":"2020","unstructured":"Mart\u00ednez-Monseny A, Casas-Alba D, Arjona C, Bolasell M, Casano P, Muchart J, et al. Okur-Chung neurodevelopmental syndrome in a patient from Spain. Am J Med Genet A. 2020;182:20\u20134. https:\/\/doi.org\/10.1002\/ajmg.a.61405.","journal-title":"Am J Med Genet A"},{"key":"1514_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000522353","volume":"13","author":"H Jafari Khamirani","year":"2022","unstructured":"Jafari Khamirani H, Zoghi S, Motealleh A, Dianatpour M, Tabei SMB, Mohammadi S, et al. Clinical features of Okur-Chung neurodevelopmental syndrome: case report and literature review. Mol Syndromol. 2022;13:381\u20138. https:\/\/doi.org\/10.1159\/000522353.","journal-title":"Mol Syndromol"},{"key":"1514_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63642","volume":"194","author":"A Blanc","year":"2024","unstructured":"Blanc A, Bonnet C, Wandzel M, Roth V, Duffourd Y, Safraou H, et al. Patient with a heterozygous pathogenic variant in CSNK2A1 gene: a new case to update the Okur-Chung neurodevelopmental syndrome. Am J Med Genet A. 2024;194:e63642. https:\/\/doi.org\/10.1002\/ajmg.a.63642.","journal-title":"Am J Med Genet A"},{"key":"1514_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8927","volume":"12","author":"J Liu","year":"2024","unstructured":"Liu J, Li Y, Andersson HC, Upadia J. Subtelomeric microdeletion in chromosome 20p13 associated with short stature. Clin Case Rep. 2024;12:e8927. https:\/\/doi.org\/10.1002\/ccr3.8927.","journal-title":"Clin Case Rep"},{"key":"1514_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1692704","volume":"16","author":"N Zhang","year":"2025","unstructured":"Zhang N, Han M, Zhao T, Tang X, Wang Z, Du Y, et al. Identification and functional analysis of a novel CSNK2A1 frameshift variant in stillbirth. Front Genet. 2025;16:1692704. https:\/\/doi.org\/10.3389\/fgene.2025.1692704.","journal-title":"Front Genet"},{"key":"1514_CR31","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/ajmg.b.32187","volume":"162B","author":"Y An","year":"2013","unstructured":"An Y, Amr SS, Torres A, Weissman L, Raffalli P, Cox G, et al. SOX12 and NRSN2 are candidate genes for 20p13 subtelomeric deletions associated with developmental delay. Am J Med Genet B Neuropsychiatr Genet. 2013;162B:832\u201340. https:\/\/doi.org\/10.1002\/ajmg.b.32187.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1514_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.739","volume":"7","author":"HH Fang","year":"2019","unstructured":"Fang HH, Liu SY, Wang YF, Chiang CM, Liu CC, Lin CM. Phenotypic features of a microdeletion in chromosome band 20p13: a case report and review of the literature. Mol Genet Genomic Med. 2019;7:e00739. https:\/\/doi.org\/10.1002\/mgg3.739.","journal-title":"Mol Genet Genomic Med"},{"key":"1514_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ajmg.a.35654","volume":"161A","author":"A Jezela-Stanek","year":"2013","unstructured":"Jezela-Stanek A, Kucharczyk M, Pelc M, Gutkowska A, Krajewska-Walasek M. 1.15 Mb microdeletion in chromosome band 20p13 associated with moderate developmental delay\u2013additional case and data review. Am J Med Genet A. 2013;161A:172\u20138. https:\/\/doi.org\/10.1002\/ajmg.a.35654.","journal-title":"Am J Med Genet A"},{"key":"1514_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejmg.2011.12.009","volume":"55","author":"S Moutton","year":"2012","unstructured":"Moutton S, Rooryck C, Toutain J, Cailley D, Bouron J, Villega F, et al. Dysmorphic features in subtelomeric 20p13 deletion excluding JAG1: a recognizable microdeletion phenotype? Eur J Med Genet. 2012;55:151\u20135. https:\/\/doi.org\/10.1016\/j.ejmg.2011.12.009.","journal-title":"Eur J Med Genet"},{"key":"1514_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.831693","volume":"9","author":"C Werner","year":"2022","unstructured":"Werner C, Gast A, Lindenblatt D, Nickelsen A, Niefind K, Jose J, et al. Structural and enzymological evidence for an altered substrate specificity in Okur-Chung neurodevelopmental syndrome mutant CK2\u03b1Lys198Arg. Front Mol Biosci. 2022;9:831693. https:\/\/doi.org\/10.3389\/fmolb.2022.831693.","journal-title":"Front Mol Biosci"},{"key":"1514_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.851547","volume":"9","author":"P Unni","year":"2022","unstructured":"Unni P, Friend J, Weinberg J, Okur V, Hochscherf J, Dominguez I. Predictive functional, statistical and structural analysis of CSNK2A1 and CSNK2B variants linked to neurodevelopmental diseases. Front Mol Biosci. 2022;9:851547. https:\/\/doi.org\/10.3389\/fmolb.2022.851547.","journal-title":"Front Mol Biosci"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01514-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:02:33Z","timestamp":1788868953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01514-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":36,"alternative-id":["1514"],"URL":"https:\/\/doi.org\/10.1038\/s10038-026-01514-6","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Ordu University Non-Interventional Clinical Research Ethics Committee (Decision No: 2026\/11, Date: 07.01.2026) as the coordinating site, with site-specific approvals as applicable. The study was conducted in accordance with the principles of the Declaration of Helsinki (2013 revision).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}